MedTrace Logo

Quantifying Collateral Perfusion in Cerebrovascular Disease-Moyamoya Disease and Stroke Patients

NCT01419275 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 126

Last updated 2017-08-30

Study results available
· View outcomes & findings →

Summary

Quantifying Collateral Perfusion in Cerebrovascular Disease-Moyamoya disease and stroke patients

Conditions

  • Cerebrovascular Accident
  • Moyamoya Disease

Interventions

DRUG

Xenon contrast agent

DEVICE

Magnetic Resonance Imaging

Arterial spin label sequence for the purpose of measuring collateral flow

Sponsors & Collaborators

Principal Investigators

  • Greg Zaharchuk · Stanford University

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-04-30
Primary Completion
2013-11-30
Completion
2013-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01419275 on ClinicalTrials.gov